Jeffrey L. Edelman

Person

Irvine, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Biodegradable intravitreal tyrosine kinase implants
- Patent number 10,881,608
- Issue date Jan 5, 2021
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-pregenen-11β-17-21-triol-3,20-dione derivatives
- Patent number 10,493,082
- Issue date Dec 3, 2019
- Allergan, Inc.
- Jeffrey L. Edelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17...
- Patent number 10,188,667
- Issue date Jan 29, 2019
- Allergan, Inc.
- Jeffrey L. Edelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ocular therapy using glucocorticoid derivatives selectively penetra...
- Patent number 10,188,665
- Issue date Jan 29, 2019
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biodegradable intravitreal tyrosine kinase implants
- Patent number 10,076,492
- Issue date Sep 18, 2018
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular therapy using glucocorticoid derivatives selectively penetra...
- Patent number 9,820,995
- Issue date Nov 21, 2017
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17...
- Patent number 9,717,743
- Issue date Aug 1, 2017
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-pregenen-11β-17-21-triol-3,20-dione derivatives
- Patent number 9,433,631
- Issue date Sep 6, 2016
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular therapy using glucocorticoid derivatives selectively penetra...
- Patent number 9,259,429
- Issue date Feb 16, 2016
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biodegradable intravitreal tyrosine kinase implants
- Patent number 9,233,070
- Issue date Jan 12, 2016
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release intraocular implants containing tyrosine kinase i...
- Patent number 8,968,766
- Issue date Mar 3, 2015
- Allergan, Inc.
- Patrick M. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisot...
- Patent number 8,969,583
- Issue date Mar 3, 2015
- Allergan, Inc.
- Thomas C. Malone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-pregenen-11β-17-21-triol-3,20-dione derivatives
- Patent number 8,906,892
- Issue date Dec 9, 2014
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21...
- Patent number 8,865,691
- Issue date Oct 21, 2014
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular therapy using glucocorticoid derivatives selectively penetra...
- Patent number 8,840,872
- Issue date Sep 23, 2014
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biodegradable intravitreal tyrosine kinase implants
- Patent number 8,512,738
- Issue date Aug 20, 2013
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors
- Patent number 8,455,656
- Issue date Jun 4, 2013
- Allergan, Inc.
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors
- Patent number 8,383,825
- Issue date Feb 26, 2013
- Allergan, Inc.
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors
- Patent number 8,143,410
- Issue date Mar 27, 2012
- Allergan, Inc.
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular therapy using glucocorticoid derivatives selectively penetra...
- Patent number 8,062,657
- Issue date Nov 22, 2011
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release intraocular implants containing tyrosine kinase i...
- Patent number 7,771,742
- Issue date Aug 10, 2010
- Allergan, Inc.
- Patrick M. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors
- Patent number 7,749,530
- Issue date Jul 6, 2010
- Allergan, Inc.
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS
- Publication number 20210121397
- Publication date Apr 29, 2021
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA...
- Publication number 20190365786
- Publication date Dec 5, 2019
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS
- Publication number 20190038551
- Publication date Feb 7, 2019
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA...
- Publication number 20180147217
- Publication date May 31, 2018
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...
- Publication number 20180125861
- Publication date May 10, 2018
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES
- Publication number 20170182062
- Publication date Jun 29, 2017
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS
- Publication number 20160199297
- Publication date Jul 14, 2016
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...
- Publication number 20160158249
- Publication date Jun 9, 2016
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STEROID CONTAINING DRUG DELIVERY SYSTEM
- Publication number 20150265633
- Publication date Sep 24, 2015
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES
- Publication number 20150057258
- Publication date Feb 26, 2015
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA...
- Publication number 20150005519
- Publication date Jan 1, 2015
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...
- Publication number 20140357609
- Publication date Dec 4, 2014
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Biodegradable Intravitreal Tyrosine Kinase Implants
- Publication number 20140031408
- Publication date Jan 30, 2014
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KINASE INHIBITORS
- Publication number 20130267497
- Publication date Oct 10, 2013
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE INTRAOCULAR IMPLANTS CONTAINING TYROSINE KINASE I...
- Publication number 20130210862
- Publication date Aug 15, 2013
- Allergan, Inc.
- Patrick M. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-PHENYL-5-UREIDOISOTHIAZOLE-4-CARBOXIMIDE AND 3-AMINO-5-PHENYLISOT...
- Publication number 20130172353
- Publication date Jul 4, 2013
- Allergan, Inc.
- Thomas C. Malone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES
- Publication number 20130123223
- Publication date May 16, 2013
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARAMCEUTICAL COMPOSITIONS AND METHODS OF USE 4-PREGENEN-11BETA-17...
- Publication number 20130123226
- Publication date May 16, 2013
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Kinase inhibitors
- Publication number 20120238558
- Publication date Sep 20, 2012
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Kinase Inhibitors
- Publication number 20120207810
- Publication date Aug 16, 2012
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...
- Publication number 20120065178
- Publication date Mar 15, 2012
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Kinase Inhibitors
- Publication number 20110263611
- Publication date Oct 27, 2011
- Allergan, Inc.
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Steroid Containing Drug Delivery Systems
- Publication number 20110077229
- Publication date Mar 31, 2011
- Allergan, Inc.
- JEFFREY L. EDELMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Kinase inhibitors
- Publication number 20090286773
- Publication date Nov 19, 2009
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Kinase inhibitors
- Publication number 20090208557
- Publication date Aug 20, 2009
- Lon T. Spada
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
Kinase inhibitors
- Publication number 20090196906
- Publication date Aug 6, 2009
- Lon T. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STEROID CONTAINING DRUG DELIVERY SYSTEMS
- Publication number 20090082321
- Publication date Mar 26, 2009
- Allergan, Inc.
- JEFFREY L. EDELMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...
- Publication number 20070088014
- Publication date Apr 19, 2007
- Allergan, Inc.
- Jeffrey L. Edelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-angiogenic sustained release intraocular implants and related...
- Publication number 20070059336
- Publication date Mar 15, 2007
- Allergan, Inc.
- Patrick M. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release intraocular drug delivery systems
- Publication number 20060182783
- Publication date Aug 17, 2006
- Allergan, Inc.
- Patrick M. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jeffrey L. Edelman

Person

Patents Grantslast 30 patents

Biodegradable intravitreal tyrosine kinase implants

4-pregenen-11β-17-21-triol-3,20-dione derivatives

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17...

Ocular therapy using glucocorticoid derivatives selectively penetra...

Biodegradable intravitreal tyrosine kinase implants

Ocular therapy using glucocorticoid derivatives selectively penetra...

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17...

4-pregenen-11β-17-21-triol-3,20-dione derivatives

Ocular therapy using glucocorticoid derivatives selectively penetra...

Biodegradable intravitreal tyrosine kinase implants

Sustained release intraocular implants containing tyrosine kinase i...

3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisot...

4-pregenen-11β-17-21-triol-3,20-dione derivatives

Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21...

Ocular therapy using glucocorticoid derivatives selectively penetra...

Biodegradable intravitreal tyrosine kinase implants

Kinase inhibitors

Kinase inhibitors

Kinase inhibitors

Ocular therapy using glucocorticoid derivatives selectively penetra...

Sustained release intraocular implants containing tyrosine kinase i...

Kinase inhibitors

Patents Applicationslast 30 patents

BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA...

BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA...

OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...

4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES

BIODEGRADABLE INTRAVITREAL TYROSINE KINASE IMPLANTS

OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...

STEROID CONTAINING DRUG DELIVERY SYSTEM

4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA...

OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...

Biodegradable Intravitreal Tyrosine Kinase Implants

KINASE INHIBITORS

SUSTAINED RELEASE INTRAOCULAR IMPLANTS CONTAINING TYROSINE KINASE I...

3-PHENYL-5-UREIDOISOTHIAZOLE-4-CARBOXIMIDE AND 3-AMINO-5-PHENYLISOT...

4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES

PHARAMCEUTICAL COMPOSITIONS AND METHODS OF USE 4-PREGENEN-11BETA-17...

Kinase inhibitors

Kinase Inhibitors

OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...

Kinase Inhibitors

Steroid Containing Drug Delivery Systems

Kinase inhibitors

Kinase inhibitors

Kinase inhibitors

STEROID CONTAINING DRUG DELIVERY SYSTEMS

OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRA...

Anti-angiogenic sustained release intraocular implants and related...

Sustained release intraocular drug delivery systems